BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies | GenomeWeb

Invitrogen Advances 8 Percent on Index

Shares of Invitrogen closed up at $58.49 at market close on Tuesday, 9 percent over last week’s close, to lead gainers over the week on BioCommerce Week’s Index to the Diversified Biology Tools Companies. Overall, the index finished up for a third-straight week at $32.19 from $31.71 one week ago (see table).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.